Title : Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells.

Pub. Date : 2013 Oct

PMID : 23877009






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Exposure of PX-866 treated cells to sorafenib reduced p62 and LAMP2 levels, decreased the ratio of LC3 to LC3II, and reduced LC3-GFP vesicle levels. Sorafenib microtubule associated protein 1 light chain 3 alpha Homo sapiens
2 Exposure of PX-866 treated cells to sorafenib reduced p62 and LAMP2 levels, decreased the ratio of LC3 to LC3II, and reduced LC3-GFP vesicle levels. Sorafenib microtubule associated protein 1 light chain 3 alpha Homo sapiens